These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15735313

  • 1. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).
    Pillonel J, Laperche S, Etablissement Français du sang.
    Euro Surveill; 2005 Feb; 10(2):5-8. PubMed ID: 15735313
    [Abstract] [Full Text] [Related]

  • 2. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J, Laperche S, Groupe "Agents Transmissibles par Transfusion" de la Société française de transfusion sanguine, Etablissement français du sang, Centre de transfusion sanguine des armées.
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [Abstract] [Full Text] [Related]

  • 3. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.
    Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S.
    Euro Surveill; 2005 Feb; 10(2):20-2. PubMed ID: 15735311
    [Abstract] [Full Text] [Related]

  • 4. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
    Offergeld R, Faensen D, Ritter S, Hamouda O.
    Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
    [Abstract] [Full Text] [Related]

  • 5. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003).
    Velati C, Fomiatti L, Baruffi L, Romanò L, Zanetti A, Gruppo Italiano per lo Studio delle Malattie Trasmissibili con la Trasfusione.
    Euro Surveill; 2005 Feb; 10(2):12-4. PubMed ID: 15735315
    [Abstract] [Full Text] [Related]

  • 6. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.
    Soldan K, Davison K, Dow B.
    Euro Surveill; 2005 Feb; 10(2):17-9. PubMed ID: 15735312
    [Abstract] [Full Text] [Related]

  • 7. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
    Niederhauser C, Schneider P, Fopp M, Ruefer A, Lévy G.
    Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314
    [Abstract] [Full Text] [Related]

  • 8. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 9. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
    Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Lętowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW.
    Vox Sang; 2012 Jan; 102(1):82-90. PubMed ID: 21933190
    [No Abstract] [Full Text] [Related]

  • 10. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ, van Drimmelen HA, Lelie PN.
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [Abstract] [Full Text] [Related]

  • 11. [Epidemiological data on infections among blood donors in Germany 2007].
    Offergeld R, Ritter S, Quabeck L, Hamouda O.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Nov; 53(11):1188-96. PubMed ID: 20976426
    [Abstract] [Full Text] [Related]

  • 12. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C, Araújo F.
    Acta Med Port; 2013 Nov; 26(4):371-6. PubMed ID: 24016646
    [Abstract] [Full Text] [Related]

  • 13. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 14. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [Abstract] [Full Text] [Related]

  • 15. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [Abstract] [Full Text] [Related]

  • 16. Fifteen years of Nucleic Acid Testing in France: Results and lessons.
    Laperche S, Tiberghien P, Roche-Longin C, Pillonel J.
    Transfus Clin Biol; 2017 Sep; 24(3):182-188. PubMed ID: 28709845
    [Abstract] [Full Text] [Related]

  • 17. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 18. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.
    Kim MJ, Park Q, Min HK, Kim HO.
    BMC Infect Dis; 2012 Jul 20; 12():160. PubMed ID: 22817275
    [Abstract] [Full Text] [Related]

  • 19. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review.
    Cable R, Lelie N, Bird A.
    Vox Sang; 2013 Feb 20; 104(2):93-9. PubMed ID: 22924987
    [Abstract] [Full Text] [Related]

  • 20. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
    Jarvis LM, Dow BC, Cleland A, Davidson F, Lycett C, Morris K, Webb B, Jordan A, Petrik J.
    Vox Sang; 2005 Oct 20; 89(3):128-34. PubMed ID: 16146504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.